SEC
Whistleblower
Advocates

August 30, 2016

AstraZeneca PLC

Foreign Corrupt Practices Act

SANCTION AMOUNT: $5,522,000

Defendants: AstraZeneca PLC

Settlement of allegations that Respondent violated the internal controls and books-and-records provisions of the FCPA as a result of its wholly-owned subsidiaries in China and Russia making improper payments to foreign officials, as incentives to purchase or prescribe AstraZeneca pharmaceuticals, and also to get reductions or dismissals of proposed financial sanctions.

Thank you for submitting some email to us.